Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Phase II data for ISIS-2302 in Crohn's disease

March 3, 1997

CCK-B/gastrin antagonists described by Rotta

March 3, 1997

ICAM-1 antisense oligonucleotide effective in murine model of colitis

Feb. 28, 1997

IND filed for SunPharm IBD treatment

Feb. 27, 1997

Axcan H. pylori trial nearing completion

Feb. 27, 1997

Candidate proton pump inhibitor described by Dainippon

Feb. 27, 1997

PLA2 inhibitors revealed by Mitsui Toatsu

Feb. 26, 1997

Korean researchers investigate antisecretory agents

Feb. 25, 1997

Provir progresses through clinical trials

Feb. 24, 1997

GalaGen's Diffistat-G advances through phase I

Feb. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...